Emblicanin A



Compound IDCDAMM00400
Common nameEmblicanin A
IUPAC name[(10R,15R)-3,4,5,21,22,23-hexahydroxy-8,13,18-trioxo-12-(3,4,5-trihydroxybenzoyl)oxy-9,14,17-trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,11,19,21-heptaen-11-yl] 3,4,5-trihydroxybenzoate
Molecular formulaC34H22O22

Experimental data

Retention time31.166
Adduct[M+H]+
Actual mz783.069
Theoretical mz783.068
Error1.85
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.15

Identifiers and class information

Inchi keyUEHSSTYZXFBDNL-UHFFFAOYNA-N
SmilesO=C(OC=1C(=O)OC2COC(=O)C=3C=C(O)C(O)=C(O)C3C4=C(O)C(O)=C(O)C=C4C(=O)OC2C1OC(=O)C5=CC(O)=C(O)C(O)=C5)C6=CC(O)=C(O)C(O)=C6
SuperclassPhenylpropanoids and polyketides
ClassTannins

Pharmacokinetic properties

Number of descriptor values(#stars)11
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)16
Number of reactive functional groups (#rtvFG)5
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)782.535
Computed dipole moment(dipole)6.118
Total solvent accessible surface area (SASA)977.545
Hydrophobic component of SASA (FOSA)67.382
Hydrophilic component of SASA (FISA)704.64
Pie component of the SASA (PISA)205.523
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1891.37
Number of hydrogen bond donors (donorHB)12
Number of hydrogen bond acceptors (accptHB)21
Free energy of solvation of dipole (dip^2/V)0.0197877
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0744172
Globularity descriptor (glob)0.756623
Predicted polarizability in cubic angstroms (QPpolrz)61.228
Predicted hexadecane/gas partition coefficient (QPlogPC16)25.152
Predicted octanol/gas partition coefficient (QPlogPoct)52.004
Predicted water/gas partition coefficient (QPlogPw)42.993
Predicted octanol/water partition coefficient (QPlogPo/w)-3.526
Predicted aqueous solubility (QPlogS)-3.761
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.363
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.45
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.002
Predicted brain/blood partition coefficient (QPlogBB)-8.607
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0
Predicted skin permeability, log Kp (QPlogKp)-12.246
PM3 calculated ionization potential (IP(ev))8.92
PM3 calculated electron affinity (EA(eV))1.139
Number of likely metabolic reactions (#metab)13
Prediction of binding to human serum albumin (QPlogKhsa)-1.178
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)413.131
Number of nitrogen and oxygen atoms (#NandO)22
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P06746POLBDNA polymerase beta (by homology)T06958SEA
P05121SERPINE1Plasminogen activator inhibitor-1T15556SEA
P14151SELLLeukocyte adhesion molecule-1T60526SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T15556DI0037Asthma[ICD-11: CA23]P05121SERPINE1
T15556DI0405Thrombosis[ICD-11: DB61-GB90]P05121SERPINE1
T60526DI0037Asthma[ICD-11: CA23]P14151SELL
T60526DI0088Circulatory system disease[ICD-11: BE2Z]P14151SELL
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025